Research following persons with dementia aged 65 and older, between 2007 to 2010, compared weight loss in individuals prescribed cholinesterase inhibitors against weight loss in persons prescribed other medications.
Individuals taking cholinesterase inhibitors had a higher risk of weight loss. The risk of weight loss may need to be considered when prescribing cholinesterase inhibitors.
Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).
Sheffrin, MM. Miao, Y. [and] Boscardin, WJ. (2015). Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System. Journal of the American Geriatrics Society. August 3rd 2015. [Epub ahead of print]. (Click here to view the PubMed abstract).